DCVC Opportunity Fund II GP, LLC

CIK 1668343 · View on SEC EDGAR ↗

Portfolio value
$17.2M
#8,921 of 9,443 by 13F value · top 94.5%
Positions
2
As of
June 30, 2026

Portfolio value QoQ: +24.1% 13F does not disclose cash

Top 10 holdings weight
100.00%
Top 25 holdings weight
100.00%
Positions above 1%
2
Effective number of positions
1.4

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q2 2026: 0.0% Est. buys $0 · sells $507,088

Median holding: 2.5 quarters Tracked Q4 2024–Q2 2026 · 50.0% still held

New positions
0
Increased
0
Decreased
1
Closed
1
On this page

Performance vs S&P 500

Tracked Q2 2025–Q2 2026
+2.0%
S&P 500 total return (same window)
+21.7%
Excess return
-19.6%

Annualized: +2.0% · S&P 500: +21.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

Healthcare
84.3%
Technology
15.7%

Full portfolio 2 positions

Type Streak 8Q trend
RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock $14,500,687 84.30% 3,951,141 $2,370,684
IONQ IonQ, Inc. Common Stock $2,700,548 15.70% 50,705 $964,232 Down ×1

Top movers (QoQ)

Security Action Shares Δ Value Δ
RXRX Price move only +0 +$2.4M
IONQ Trimmed -10K +$964K

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarter Shares before Value before Price since exit
RKLB Sept. 30, 2025 2,663,139 $95,260,482 53.5%
RKLBXXXX June 30, 2025 3,388,249 $60,581,892 No longer tracked